Introduction Population-based studies have shown that fracture risk is increased in MGUS. 1, 2 Previously, 3 we used high-resolution peripheral quantitative computed tomography (HRpQCT) imaging of the distal radius to demonstrate that MGUS patients have significantly altered trabecular bone microarchitecture, but also greater bone size relative to matched controls. However, the impact of these skeletal alterations on bone strength, which can be assessed from
HRpQCT images using micro-FE 4 is unknown. Moreover, evidence suggests cortical bone porosity may be more important for bone strength and fracture risk than trabecular bone microarchitectural changes. 5, 6 Recent work demonstrates that the default HRpQCT cortical bone analysis previously utilized 3 performs poorly for subjects with thin or porous cortices. 7 and 100 age-, sex-, and body mass index (BMI)-matched (1:2 ratio) controls from an agestratified random sample of Olmsted County, Minnesota, residents. 10 Reflecting the local ethnic composition, 11 97% of subjects were white. 5 Study protocol. All procedures were conducted at the Mayo Clinic outpatient Clinical
Research Unit (Rochester, Minnesota). Anthropometic data were collected on all subjects.
Bone microarchitecture and strength of the non-dominant distal radius were assessed by HRpQCT; data from 3 scans (1 MGUS/2 controls) were excluded because of motion artifact.
HRpQCT imaging. Details regarding distal radial HRpQCT measurements and the default image analysis protocol have been described previously. 3 In the present analysis, we used the recently developed extended cortical analysis 8 were made using an analysis of variance model adjusted for age and sex. Testing was performed at a significance level of p<0.05 (two-tailed). Figure 1A shows representative cross-sectional distal radius HRpQCT images (slice 55 of 110) from a female MGUS patient (left) and an age-, sex-, and BMI-matched control subject (right), with the MGUS patient having both cortical thinning and deficits in cortical vBMD relative to the matched control. Further, MGUS was associated with higher cortical porosity, particularly along the medial and posterior borders of the distal radius. 6 Clinical characteristics and bone parameters of the MGUS and control groups (Table 1) demonstrates that the MGUS and control groups were similar in age, height, weight and BMI. MGUS patients had significantly higher cortical porosity (+16.8%; P<0.05; Figure 1B) Figure 1C ).
Results and Discussion
While MGUS patients are at increased risk for fracture1 ,2 and progression to multiple myeloma or a related plasma cell cancer, 14 clinically, MGUS patients are followed without treatment until progression. 15 In this study, we used HRpQCT a FE MGUS patients have altered cortical microarchitecture and lower biomechanical bone strength versus matched controls, factors likely significant for explaining their increased fracture risk.
Although dual-energy X-ray absorptiometry (DXA) is clinically used for monitoring skeletal health, it cannot separate trabecular from cortical bone, a shortcoming which limits its ability to detect changes within these skeletal compartments. An advantage of HRpQCT is that such separation is readily performed, and as indicated by our findings, HRpQCT imaging clearly demonstrates that MGUS is associated with significantly higher cortical porosity.
Despite their larger radial bone size, 3 MGUS patients had significantly lower cortical vBMD and tended to have thinner cortices relative to controls. These results extend our previous findings 3 demonstrating altered trabecular microarchitecture with MGUS.
A FE
biomechanical properties in response to a simulated axial compression test. 4 Our findings that failure load and stiffness both tended to be lower in MGUS patients are consistent with the suggestion that bone strength is reduced in MGUS. Notably, these deficits did not reach statistical significance, likely because of the compensatory increase in bone size seen in 7 MGUS patients, 3 an increase likely resulting from progressive periosteal (outer surface) bone apposition with concomitantly increased endocortical (inner surface) resorption, ultimately resulting in cortical thinning. Such outward cortical displacement increases resistance to bending stresses, providing a partial biomechanical adaptation to limit the overall loss of bone strength resulting from decreased cortical thickness. 16 Consistent with this premise, MGUS patients had significantly lower radial apparent modulus (bone strength corrected for cross-sectional area) compared to controls.
The importance of cortical bone morphology in bone strength and fracture prevention is highlighted by observations that cortical bone comprises over 80% of the adult skeleton, 17 and that after age 65, most appendicular bone loss is cortical. 18 Further, 80% of fractures after age 65 occur at predominantly cortical skeletal sites. 19 Thus, the cortical bone deterioration we observed in MGUS patients is of significant clinical concern, and emphasizes the need for treatments that prevent such bone loss.
A limitation of our study is that currently only cross-sectional data are available. Thus, longterm consequences of the cortical bone abnormalities we observed in the MGUS patients remain unknown, although we plan to examine this question by longitudinally following this cohort. Another potential concern is that our HRpQCT measurements were limited to the radius. Lastly, future studies are necessary to determine whether the identified skeletal abnormalities are worse in patients with multiple myeloma or related plasma cell malignancies.
In conclusion, despite their larger radial bone size, MGUS patients have compromised cortical microarchitecture (i.e., increased cortical bone porosity) and reduced bone strength relative to controls. Our findings underscore the need to further delineate the factors that regulate bone microarchitecture in MGUS, both to better identify those patients at greatest fracture risk and to develop therapies to limit MGUS-associated bone loss. 
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